Transforming growth factor β1 modulates amyloid β-induced glial activation through the smad3-dependent induction of MAPK phosphatase-1

Journal of Alzheimer's Disease

Volumn 32, Issue 2, 2012, Pages 417-429

  Flores, Betsi ^a   Von Bernhardi, Rommy ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

Alzheimer's disease; amyloid ; glial cells; inflammation; MKP 1 phosphatase; TGF 1

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE PHOSPHATASE 1; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR RELA; TRANSFORMING GROWTH FACTOR BETA1;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; GLIA CELL; INFLAMMATION; NEUROPROTECTION; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 84866260694     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-120721     Document Type: Article

References (65)

1. Block ML, Hong JS (2005) Microglia and inflammationmediated neurodegeneration: Multiple triggers with a common mechanism. Prog Neurobiol 76, 77-98.
2. Kulinsky VI (2007) Biochemical aspects of inflammation. Biochem Moscow 72, 595-607.
3. Mrak RE, Griffin ST (2005) Glia and their cytokines in progression of neurodegeneration. Neurobiol Aging 26, 349-354.
4. Wyss-Coray T (2006) Inflammation in Alzheimer disease: Driving force, bystander or beneficial response? Nat Med 12, 1005-1015.
5. Frank-Cannon TC, Alto LT, McAlpine FE, TanseyMG(2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol Neurodegener 4, 47-59.
6. Gao HM, Hong JS (2008) Why neurodegenerative diseases are progressive: Uncontrolled inflammation drives disease progression. Trends Immunol 29, 357-365.
7. von Bernhardi R (2007) Glial cell dysregulation: A new perspective on Alzheimer disease. Neurotox Res 12, 215-232.
8. Glass CK, Saijo K,Winner B, MarchettoMC,GageFH(2010) Mechanisms underlying inflammation in neurodegeneration. Cell 140, 918-934.
9. von Bernhardi R, Tichauer J, Eugen'in J (2010) Agingdependent changes of microglial cells and their relevance for neurodegenerative disorders. J Neurochem 112, 1099-1114.
10. Heneka MT, O'Banion MK, Terwel D, Kummer MP (2010) Neuroinflammatory processes in Alzheimer's disease. J Neural Transm 117, 919-947.
11. Van Eldik LJ, Thompson WL, Ralay Ranaivo H, Behanna HA, Watterson DM (2007) Glia proinflammatory cytokine upregulation as a therapeutic target for neurodegenerative diseases: Function-based and target-based discovery approaches. Int Rev Neurobiol 82, 277-296.
12. Pei JJ, Braak E, Braak H, Grundke-Iqbal I, Iqbal K, Winblad B, Cowburn RF (2001) Localization of active forms of C-jun kinase (JNK) and p38 kinase in Alzheimer's disease brains at different stages of neurofibrillary degeneration. J Alzheimers Dis 3, 41-48.
13. Sun A, Liu M, Nguyen XV, Bing G (2003) P38 MAP kinase is activated at early stages in Alzheimer's disease brain. Exp Neurol 183, 394-405.
14. Feijoo C, Campbell DG, Jakes R, Goedert M, Cuenda A (2005) Evidence that phosphorylation of the microtubuleassociated protein Tau by SAPK4/p38d at Thr50 promotes microtubule assembly. J Cell Sci 118, 397-408.
15. Churcher I (2006) Tau therapeutic strategies for the treatment of Alzheimer's disease. Curr Top Med Chem 6, 579-595.
16. Zhu X, Mei M, Lee HG, Wang Y, Han J, Perry G, Smith MA (2005) P38 activation mediates amyloid-beta cytotoxicity. Neurochem Res 30, 791-796.
17. Saha RN, Jana M, Pahan K (2006) Regulation of inducible nitric oxide synthase gene in glial cells. Antioxid Redox Signal 8, 929-947.
18. Munoz L, Ammit AJ (2010) Targeting p38 MAPK pathway for the treatment of Alzheimer's disease. Neuropharmacology 58, 561-568.
19. Spriggs DR, Deutsch S, Kufe DW(1992) Genomic structure, induction, and production of TNF-. Immunol Ser 56, 3-34.
20. Dean JL, Sully G, Clark AR, Saklatvala J (2004) The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway mediated Mrna stabilization. Cell Signal 16, 1113-1121.
21. Liu Y, Shepherd EG, Nelin LD (2007) MAPK phosphatases - regulating the immune response. Nat Rev Immunol 7, 202- 212.
22. Boutros T, Chevet E, Metrakos P (2008) Mitogen-activated protein (MAP) kinase/MAP kinase phosphatase regulation: Roles in cell growth, death and cancer. Pharmacol Rev 60, 261-310.
23. Eljaschewitsch E,Witting A, Mawrin C, Lee T, Schmidt PM, Wolf S, Hoertnagl H, Raine CS, Schneider-Stock R, Nitsch R, Ullrich O (2006) The endocannabinoid anandamide protects neurons during CNS inflammation by induction of MKP-1 in microglial cells. Neuron 49, 67-79.
24. Lee JH, Woo JH, Woo SU, Kim KS, Park SM, Joe E, Jou I (2008) The 15-deoxy-d12,14-prostaglandin J2 suppresses monocyte chemoattractant protein-1 expression in IFNgamma stimulated astrocytes through induction of MAPK Phosphatase-1. J Immunol 181, 8642-8649.
25. Schmierer B, Hill CS (2007) TGF-SMAD signal transduction: Molecular specificity and functional flexibility. Nat Rev Mol Cell Biol 8, 970-982.
26. Heldin CH, Moustakas A (2012) Role of Smads in TGF signaling. Cell Tissue Res 347, 21-36.
27. Hu S, Sheng WS, Peterson PK, Chao CC (1995) Cytokine modulation of murine microglial cell superoxide production. Glia 13, 45-50.
28. Lieb K, Engels S, Fiebich BL (2003) Inhibition of LPSinduced iNOS and NO synthesis in primary rat microglial cells. Neurochem Int 42, 131-137.
29. Herrera-Molina R, von Bernhardi R (2005) Transforming growth factor-1 produced by hippocampal cells modulates microglial reactivity in culture. Neurobiol Dis 19, 229-236.
30. Prehn JH, Bindokas VP, Jordan J (1996) Protective effect of transforming growth factor-1 on -amyloid neurotoxicity in rat hippocampal neurons. Mol Pharmacol 49, 319-328.
31. Caraci F, Battaglia G, Busceti C (2008) TGF-1 protects against A-neurotoxicity via the phosphatidylinositol-3- kinase pathway. Neurobiol Dis 30, 234-242.
32. Wyss-Coray T, Lin C, Yan F (2001) TGF-1 promotes microglial amyloid-beta clearance and reduces plaque burden in transgenic mice. Nat Med 7, 612-618.
33. Werner F, Jain MK, Feinberg MW, Sibinga NE, Pellacani A, Wiesel P, Chin MT, Topper JN, Perrella MA, Lee ME (2000) Transforming growth factor-beta 1 inhibition of macrophage activation is mediated via Smad3. J Biol Chem 275, 36653- 36658.
34. Le Y, Iribarren P, GongW, Cui Y, Zhang X,Wang JM (2004) TGF-beta1 disrupts endotoxin signaling in microglial cells through Smad3 and MAPK pathways. J Immunol 173, 962- 968.
35. Docagne F, Nicole O, Gabriel C, Fern'andez-Monreal M, Lesn'e S, Ali C, Plawinski L, Carmeliet P, MacKenzie ET, Buisson A, Vivien D (2002) Smad3-dependent induction of plasminogen activator inhibitor-1 in astrocytes mediates neuroprotective activity of transforming growth factor-beta 1 against NMDA-induced necrosis. Mol Cell Neurosci 21, 634- 644.
36. Tichauer J, von Bernhardi R (2012) TGF stimulates A uptake by microglia through Smad3-dependent mechanisms. J Neurosci Res 90, 1970-1980.
37. Colangelo V, Schurr J, Ball MJ, Pelaez RP, Bazan NG, Lukiw WJ (2002) Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1:Transcription and neurotrophic factor down-regulation and up-regulation of apoptotic and pro-inflammatory signaling. J Neurosci Res 70, 462-473.
38. Katsel PL, Davis KL, Haroutunian V (2005) Large-scale microarray studies of gene expression in multiple regions of the brain in schizophrenia and Alzheimer's disease. Int Rev Neurobiol 63, 41-82.
39. Luterman JD, Haroutunian V, Yemul S (2000) Cytokine gene expression as a function of the clinical progression of Alzheimer disease dementia. Arch Neurol 57, 1153-1160.
40. Tesseur I, Zou K, Esposito L (2006) Deficiency in neuronal TGF- signaling promotes neurodegeneration and Alzheimer's pathology. J Clin Invest 116, 3060-3069.
41. Ueberham U, Ueberham E, Gruschka H, Arendt T (2006) Altered subcellular location of phosphorylated Smads in Alzheimer's disease. Eur J Neurosci 24, 2327-2334.
42. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor in human disease. N Engl J Med 342, 1350-1358.
43. Á lvarez A, Alarcón R, Opazo C, Campos EO, Munoz FJ, Caldeŕon FH, Dajas F, Gentry MK, Doctor BP, De Mello FG, Inestrosa NC (1998) Stable complexes involving acetylcholinesterase and amyloid- peptide change the biochemicalproperties of the enzyme and increase the neurotoxicity of Alzheimer's fibrils. J Neurosci 18, 3213-3223.
44. Tichauer J, Saud K, von Bernhardi R (2007) Modulation by astrocytes of microglial cell-mediated neuroinflammation: Effect on the activation of microglial signaling pathways. Neuroimmunomodulation 14, 168-174.
45. Pfeiffer S, Gorren AC, Schmidt K, Werner ER, Hanser B, Bohle DS, Mayer B (1997) Metabolic fate of peroxynitrite in aqueous solution. J Biol Chem 272, 3465-3470.
46. Akama KT, Albanese C, Pestell RG, van Eldik L (1998) Amyloid -peptide stimulates nitric oxide production in astrocytes through an NF-κB- dependent mechanism. Proc Natl Acad Sci U S A 95, 5795-5800.
47. HuJ,AkamaKT, Krafft GA, ChromyBA,Van Eldik LJ (1998) Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release. Brain Res 785, 195-206.
48. Akama KT, Van Eldik LJ (2000) -Amyloid stimulation of inducible nitric-oxide synthase in astrocytes is interleukin-1- and tumor necrosis factor- (TNF)-dependent, and involves a TNF receptor-associated factor- and NFκB-inducing kinase-dependent signaling mechanism. J Biol Chem 275, 7918-7924.
49. Jana M, Palencia CA, Pahan K (2008) Fibrillar amyloidbeta peptides activate microglia via TLR2: Implications for Alzheimer's disease. J Immunol 181, 7254-7262.
50. Hirose Y, Katayama M, Stokoe D, Haas-Kogan DA, Berger MS, Pieper RO (2003) The p38 mitogen-activated protein kinase pathway links the DNA mismatch repair system to the G2 checkpoint and to resistance to chemotherapeutic DNAmethylating agents. Mol Cell Biol 23, 8306-8315.
51. Saha RN, Jana M, Pahan K (2007) MAPK p38 regulates transcriptional activity of NF-κB in primary human astrocytes via acetylation of p65. J Immunol 179, 7101-7109.
52. Su D, Peng X, Zhu S, Huang Y, Dong Z, Zhang Y, Zhang J, Liang Q, Lu J, Huang B (2011) Role of p38 MAPK pathway in BMP4-mediated Smad-dependent premature senescence in lung cancer cells. Biochem J 433, 333-343.
53. Saud K, Herrera-Molina R, von Bernhardi R (2005) Proand anti-inflammatory cytokines regulate the ERK pathways: Implication of the timing for the activation of microglial cells. Neurotox Res 8, 277-287.
54. Jinnin M, Ihn H, Tamaki K (2006) Characterization of SIS3, a novel specific inhibitor of Smad3, and its effect on transforming growth factor-beta1-induced extracellular matrix expression. Mol Pharmacol 69, 597-607.
55. von Bernhardi R, Tichauer J, Eugen'in-von Bernhardi L (2011) Proliferating culture of aged microglia for the study of neurodegenerative diseases. J Neurosci Methods 202, 65-69.
56. von Bernhardi R, Eugen'in J (2004) Microglial reactivity to -amyloid is modulated by astrocytes and proinflammatory factors. Brain Res 1025, 186-193.
57. O'Neill LA, Kaltschmidt C (1997) NF-κB: A crucial transcription factor for glial and neuronal cell function. Trends Neurosci 20, 252-258.
58. Tran MH, Yamada K, Olariu A, Mizuno M, Ren XH, Nabeshima T (2001) Amyloid -peptide induces nitric oxide production in rat hippocampus: Association with cholinergic dysfunction and amelioration by inducible nitric oxide synthase inhibitors. FASEB J 15, 1407-1409.
59. Wang Q, Wu J, Rowan MJ, Anwyl R (2005) Beta-amyloid inhibition of long-term potentiation is mediated via tumor necrosis factor. Eur J Neurosci 22, 2827-2832.
60. He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, Staufenbiel M, Li R, Shen Y (2007) Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol 178, 829-841.
61. Medeiros R, Prediger RD, Passos GF, Pandolfo P, Duarte FS, Franco JL, Dafre AL, Di Giunta G, Figueiredo CP, Takahashi RN, Campos MM, Calixto JB (2007) Connecting TNF-alpha signaling pathways to iNOS expression in a mouse model of Alzheimer's disease: Relevance for the behavioral and synaptic deficits induced by amyloid beta protein. J Neurosci 27, 5394-5404.
62. Jono H,XuH, Kai H, Lim DJ,KimYS, Feng XH, Li JD (2003) Transforming growth factor-Smad signaling pathway negatively regulates nontypeable Haemophilus influenzaeinduced MUC5AC mucin transcription via mitogen-activated protein kinase (MAPK) phosphatase-1-dependent inhibition of p38 MAPK. J Biol Chem 278, 27811-27819.
63. Tong X, Hamel E (2007) Transforming growth factor-1 impairs Endothelin-1-mediated contraction of brain vessels by inducing Mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase. Mol Pharmacol 72, 1476-1483.
64. Ram'irez G, Rey S, von Bemhardi R (2008) Proinflammatory stimuli induce microglial cellmediated APP- and A- neurotoxicity in hippocampal cultures. J Alzheimers Dis 15, 45-59.
65. Herrera-Molina R, Flores B, Orellana JA, von Bemhardi R (2012) Modulation of interferon-γ-induced glial cell activation by transforming growth factor 1: A role for STAT1 and MAPK pathways. J Neurochem 123, 113-123.